 | • レポートコード：MRC2-11QY12157 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヘモグロビン症のグローバル市場について調査・分析したレポートです。種類別（鎌状赤血球症、アルファサラセミア、ベータサラセミア）市場規模、用途別（病院、診断研究所、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヘモグロビン症の競争状況、市場シェア ・世界のヘモグロビン症市場：種類別市場規模 2015年-2020年（鎌状赤血球症、アルファサラセミア、ベータサラセミア） ・世界のヘモグロビン症市場：種類別市場規模予測 2021年-2026年（鎌状赤血球症、アルファサラセミア、ベータサラセミア） ・世界のヘモグロビン症市場：用途別市場規模 2015年-2020年（病院、診断研究所、クリニック） ・世界のヘモグロビン症市場：用途別市場規模予測 2021年-2026年（病院、診断研究所、クリニック） ・北米のヘモグロビン症市場分析：米国、カナダ ・ヨーロッパのヘモグロビン症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヘモグロビン症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヘモグロビン症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヘモグロビン症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Diagnostics、Bio-Rad Laboratories、Danaher Corporation、Mindray Medical International、Nexcelom Bioscience、Nihon Kohden、PerkinElmer、Siemens Healthineers、Sysmex Corporation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hemoglobinopathies are a diverse set of congenital blood ailments that are a consequence of disparities in the structure and/or synthesis of hemoglobin. Hemoglobinopathies are genetic single-gene disorders that lead to an abnormal structure of one of the globin chains of the hemoglobin molecule, rendering it unable to carry oxygen through the body, which leads to anemia or other medical abnormalities. The most common hemoglobinopathies are sickle cell disease, alpha thalassemia, and beta thalassemia.
Market Analysis and Insights: Global Hemoglobinopathy Market
The global Hemoglobinopathy market size is projected to reach US$ 283 million by 2026, from US$ 270 million in 2020, at a CAGR of 4.5%% during 2021-2026.
Global Hemoglobinopathy Scope and Market Size
Hemoglobinopathy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemoglobinopathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Diagnostics
Bio-Rad Laboratories
Danaher Corporation
Mindray Medical International
Nexcelom Bioscience
Nihon Kohden
PerkinElmer
Siemens Healthineers
Sysmex Corporation
Market segment by Type, the product can be split into
Sickle cell disease
Alpha thalassemia
Beta thalassemia
Market segment by Application, split into
Hospitals
Diagnostic laboratories
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemoglobinopathy Revenue
1.4 Market by Type
1.4.1 Global Hemoglobinopathy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sickle cell disease
1.4.3 Alpha thalassemia
1.4.4 Beta thalassemia
1.5 Market by Application
1.5.1 Global Hemoglobinopathy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic laboratories
1.5.4 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hemoglobinopathy Market Perspective (2015-2026)
2.2 Global Hemoglobinopathy Growth Trends by Regions
2.2.1 Hemoglobinopathy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemoglobinopathy Historic Market Share by Regions (2015-2020)
2.2.3 Hemoglobinopathy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hemoglobinopathy Market Growth Strategy
2.3.6 Primary Interviews with Key Hemoglobinopathy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hemoglobinopathy Players by Market Size
3.1.1 Global Top Hemoglobinopathy Players by Revenue (2015-2020)
3.1.2 Global Hemoglobinopathy Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemoglobinopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemoglobinopathy Market Concentration Ratio
3.2.1 Global Hemoglobinopathy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Revenue in 2019
3.3 Hemoglobinopathy Key Players Head office and Area Served
3.4 Key Players Hemoglobinopathy Product Solution and Service
3.5 Date of Enter into Hemoglobinopathy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hemoglobinopathy Historic Market Size by Type (2015-2020)
4.2 Global Hemoglobinopathy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hemoglobinopathy Market Size by Application (2015-2020)
5.2 Global Hemoglobinopathy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hemoglobinopathy Market Size (2015-2020)
6.2 Hemoglobinopathy Key Players in North America (2019-2020)
6.3 North America Hemoglobinopathy Market Size by Type (2015-2020)
6.4 North America Hemoglobinopathy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hemoglobinopathy Market Size (2015-2020)
7.2 Hemoglobinopathy Key Players in Europe (2019-2020)
7.3 Europe Hemoglobinopathy Market Size by Type (2015-2020)
7.4 Europe Hemoglobinopathy Market Size by Application (2015-2020)
8 China
8.1 China Hemoglobinopathy Market Size (2015-2020)
8.2 Hemoglobinopathy Key Players in China (2019-2020)
8.3 China Hemoglobinopathy Market Size by Type (2015-2020)
8.4 China Hemoglobinopathy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hemoglobinopathy Market Size (2015-2020)
9.2 Hemoglobinopathy Key Players in Japan (2019-2020)
9.3 Japan Hemoglobinopathy Market Size by Type (2015-2020)
9.4 Japan Hemoglobinopathy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hemoglobinopathy Market Size (2015-2020)
10.2 Hemoglobinopathy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemoglobinopathy Market Size by Type (2015-2020)
10.4 Southeast Asia Hemoglobinopathy Market Size by Application (2015-2020)
11 India
11.1 India Hemoglobinopathy Market Size (2015-2020)
11.2 Hemoglobinopathy Key Players in India (2019-2020)
11.3 India Hemoglobinopathy Market Size by Type (2015-2020)
11.4 India Hemoglobinopathy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hemoglobinopathy Market Size (2015-2020)
12.2 Hemoglobinopathy Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemoglobinopathy Market Size by Type (2015-2020)
12.4 Central & South America Hemoglobinopathy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Diagnostics
13.1.1 Abbott Diagnostics Company Details
13.1.2 Abbott Diagnostics Business Overview
13.1.3 Abbott Diagnostics Hemoglobinopathy Introduction
13.1.4 Abbott Diagnostics Revenue in Hemoglobinopathy Business (2015-2020))
13.1.5 Abbott Diagnostics Recent Development
13.2 Bio-Rad Laboratories
13.2.1 Bio-Rad Laboratories Company Details
13.2.2 Bio-Rad Laboratories Business Overview
13.2.3 Bio-Rad Laboratories Hemoglobinopathy Introduction
13.2.4 Bio-Rad Laboratories Revenue in Hemoglobinopathy Business (2015-2020)
13.2.5 Bio-Rad Laboratories Recent Development
13.3 Danaher Corporation
13.3.1 Danaher Corporation Company Details
13.3.2 Danaher Corporation Business Overview
13.3.3 Danaher Corporation Hemoglobinopathy Introduction
13.3.4 Danaher Corporation Revenue in Hemoglobinopathy Business (2015-2020)
13.3.5 Danaher Corporation Recent Development
13.4 Mindray Medical International
13.4.1 Mindray Medical International Company Details
13.4.2 Mindray Medical International Business Overview
13.4.3 Mindray Medical International Hemoglobinopathy Introduction
13.4.4 Mindray Medical International Revenue in Hemoglobinopathy Business (2015-2020)
13.4.5 Mindray Medical International Recent Development
13.5 Nexcelom Bioscience
13.5.1 Nexcelom Bioscience Company Details
13.5.2 Nexcelom Bioscience Business Overview
13.5.3 Nexcelom Bioscience Hemoglobinopathy Introduction
13.5.4 Nexcelom Bioscience Revenue in Hemoglobinopathy Business (2015-2020)
13.5.5 Nexcelom Bioscience Recent Development
13.6 Nihon Kohden
13.6.1 Nihon Kohden Company Details
13.6.2 Nihon Kohden Business Overview
13.6.3 Nihon Kohden Hemoglobinopathy Introduction
13.6.4 Nihon Kohden Revenue in Hemoglobinopathy Business (2015-2020)
13.6.5 Nihon Kohden Recent Development
13.7 PerkinElmer
13.7.1 PerkinElmer Company Details
13.7.2 PerkinElmer Business Overview
13.7.3 PerkinElmer Hemoglobinopathy Introduction
13.7.4 PerkinElmer Revenue in Hemoglobinopathy Business (2015-2020)
13.7.5 PerkinElmer Recent Development
13.8 Siemens Healthineers
13.8.1 Siemens Healthineers Company Details
13.8.2 Siemens Healthineers Business Overview
13.8.3 Siemens Healthineers Hemoglobinopathy Introduction
13.8.4 Siemens Healthineers Revenue in Hemoglobinopathy Business (2015-2020)
13.8.5 Siemens Healthineers Recent Development
13.9 Sysmex Corporation
13.9.1 Sysmex Corporation Company Details
13.9.2 Sysmex Corporation Business Overview
13.9.3 Sysmex Corporation Hemoglobinopathy Introduction
13.9.4 Sysmex Corporation Revenue in Hemoglobinopathy Business (2015-2020)
13.9.5 Sysmex Corporation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hemoglobinopathy Key Market Segments
Table 2. Key Players Covered: Ranking by Hemoglobinopathy Revenue
Table 3. Ranking of Global Top Hemoglobinopathy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemoglobinopathy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Sickle cell disease
Table 6. Key Players of Alpha thalassemia
Table 7. Key Players of Beta thalassemia
Table 8. Global Hemoglobinopathy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Hemoglobinopathy Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Hemoglobinopathy Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Hemoglobinopathy Market Share by Regions (2015-2020)
Table 12. Global Hemoglobinopathy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Hemoglobinopathy Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Hemoglobinopathy Market Growth Strategy
Table 18. Main Points Interviewed from Key Hemoglobinopathy Players
Table 19. Global Hemoglobinopathy Revenue by Players (2015-2020) (Million US$)
Table 20. Global Hemoglobinopathy Market Share by Players (2015-2020)
Table 21. Global Top Hemoglobinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy as of 2019)
Table 22. Global Hemoglobinopathy by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hemoglobinopathy Product Solution and Service
Table 25. Date of Enter into Hemoglobinopathy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hemoglobinopathy Market Size by Type (2015-2020) (Million US$)
Table 28. Global Hemoglobinopathy Market Size Share by Type (2015-2020)
Table 29. Global Hemoglobinopathy Revenue Market Share by Type (2021-2026)
Table 30. Global Hemoglobinopathy Market Size Share by Application (2015-2020)
Table 31. Global Hemoglobinopathy Market Size by Application (2015-2020) (Million US$)
Table 32. Global Hemoglobinopathy Market Size Share by Application (2021-2026)
Table 33. North America Key Players Hemoglobinopathy Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Hemoglobinopathy Market Share (2019-2020)
Table 35. North America Hemoglobinopathy Market Size by Type (2015-2020) (Million US$)
Table 36. North America Hemoglobinopathy Market Share by Type (2015-2020)
Table 37. North America Hemoglobinopathy Market Size by Application (2015-2020) (Million US$)
Table 38. North America Hemoglobinopathy Market Share by Application (2015-2020)
Table 39. Europe Key Players Hemoglobinopathy Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Hemoglobinopathy Market Share (2019-2020)
Table 41. Europe Hemoglobinopathy Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Hemoglobinopathy Market Share by Type (2015-2020)
Table 43. Europe Hemoglobinopathy Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Hemoglobinopathy Market Share by Application (2015-2020)
Table 45. China Key Players Hemoglobinopathy Revenue (2019-2020) (Million US$)
Table 46. China Key Players Hemoglobinopathy Market Share (2019-2020)
Table 47. China Hemoglobinopathy Market Size by Type (2015-2020) (Million US$)
Table 48. China Hemoglobinopathy Market Share by Type (2015-2020)
Table 49. China Hemoglobinopathy Market Size by Application (2015-2020) (Million US$)
Table 50. China Hemoglobinopathy Market Share by Application (2015-2020)
Table 51. Japan Key Players Hemoglobinopathy Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Hemoglobinopathy Market Share (2019-2020)
Table 53. Japan Hemoglobinopathy Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Hemoglobinopathy Market Share by Type (2015-2020)
Table 55. Japan Hemoglobinopathy Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Hemoglobinopathy Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Hemoglobinopathy Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Hemoglobinopathy Market Share (2019-2020)
Table 59. Southeast Asia Hemoglobinopathy Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Hemoglobinopathy Market Share by Type (2015-2020)
Table 61. Southeast Asia Hemoglobinopathy Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Hemoglobinopathy Market Share by Application (2015-2020)
Table 63. India Key Players Hemoglobinopathy Revenue (2019-2020) (Million US$)
Table 64. India Key Players Hemoglobinopathy Market Share (2019-2020)
Table 65. India Hemoglobinopathy Market Size by Type (2015-2020) (Million US$)
Table 66. India Hemoglobinopathy Market Share by Type (2015-2020)
Table 67. India Hemoglobinopathy Market Size by Application (2015-2020) (Million US$)
Table 68. India Hemoglobinopathy Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Hemoglobinopathy Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Hemoglobinopathy Market Share (2019-2020)
Table 71. Central & South America Hemoglobinopathy Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Hemoglobinopathy Market Share by Type (2015-2020)
Table 73. Central & South America Hemoglobinopathy Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Hemoglobinopathy Market Share by Application (2015-2020)
Table 75. Abbott Diagnostics Company Details
Table 76. Abbott Diagnostics Business Overview
Table 77. Abbott Diagnostics Product
Table 78. Abbott Diagnostics Revenue in Hemoglobinopathy Business (2015-2020) (Million US$)
Table 79. Abbott Diagnostics Recent Development
Table 80. Bio-Rad Laboratories Company Details
Table 81. Bio-Rad Laboratories Business Overview
Table 82. Bio-Rad Laboratories Product
Table 83. Bio-Rad Laboratories Revenue in Hemoglobinopathy Business (2015-2020) (Million US$)
Table 84. Bio-Rad Laboratories Recent Development
Table 85. Danaher Corporation Company Details
Table 86. Danaher Corporation Business Overview
Table 87. Danaher Corporation Product
Table 88. Danaher Corporation Revenue in Hemoglobinopathy Business (2015-2020) (Million US$)
Table 89. Danaher Corporation Recent Development
Table 90. Mindray Medical International Company Details
Table 91. Mindray Medical International Business Overview
Table 92. Mindray Medical International Product
Table 93. Mindray Medical International Revenue in Hemoglobinopathy Business (2015-2020) (Million US$)
Table 94. Mindray Medical International Recent Development
Table 95. Nexcelom Bioscience Company Details
Table 96. Nexcelom Bioscience Business Overview
Table 97. Nexcelom Bioscience Product
Table 98. Nexcelom Bioscience Revenue in Hemoglobinopathy Business (2015-2020) (Million US$)
Table 99. Nexcelom Bioscience Recent Development
Table 100. Nihon Kohden Company Details
Table 101. Nihon Kohden Business Overview
Table 102. Nihon Kohden Product
Table 103. Nihon Kohden Revenue in Hemoglobinopathy Business (2015-2020) (Million US$)
Table 104. Nihon Kohden Recent Development
Table 105. PerkinElmer Company Details
Table 106. PerkinElmer Business Overview
Table 107. PerkinElmer Product
Table 108. PerkinElmer Revenue in Hemoglobinopathy Business (2015-2020) (Million US$)
Table 109. PerkinElmer Recent Development
Table 110. Siemens Healthineers Business Overview
Table 111. Siemens Healthineers Product
Table 112. Siemens Healthineers Company Details
Table 113. Siemens Healthineers Revenue in Hemoglobinopathy Business (2015-2020) (Million US$)
Table 114. Siemens Healthineers Recent Development
Table 115. Sysmex Corporation Company Details
Table 116. Sysmex Corporation Business Overview
Table 117. Sysmex Corporation Product
Table 118. Sysmex Corporation Revenue in Hemoglobinopathy Business (2015-2020) (Million US$)
Table 119. Sysmex Corporation Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemoglobinopathy Market Share by Type: 2020 VS 2026
Figure 2. Sickle cell disease Features
Figure 3. Alpha thalassemia Features
Figure 4. Beta thalassemia Features
Figure 5. Global Hemoglobinopathy Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic laboratories Case Studies
Figure 8. Clinics Case Studies
Figure 9. Hemoglobinopathy Report Years Considered
Figure 10. Global Hemoglobinopathy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hemoglobinopathy Market Share by Regions: 2020 VS 2026
Figure 12. Global Hemoglobinopathy Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hemoglobinopathy Market Share by Players in 2019
Figure 15. Global Top Hemoglobinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hemoglobinopathy Revenue in 2019
Figure 17. North America Hemoglobinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hemoglobinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hemoglobinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hemoglobinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hemoglobinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hemoglobinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hemoglobinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
鎌状赤血球の世界市場（～2026年） The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some fac…- 血管閉塞症・鎌状赤血球症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-20…
- 鎌状赤血球症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sickle Cell Disease Drug Market The global Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Sickle Cell Disease Drug Scope and Market Size Sickle Cell Diseas…
- ヘモグロビン症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Hemoglobinopathies Drugs Market The global Hemoglobinopathies Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hemoglobinopathies Drugs Scope and Market Size Hemoglobinopathies…
- 幹細胞臍帯血の世界市場（～2026年） Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered uniq…